KREBSBIO - Krebs Biochemicals & Industries

Krebs Biochemicals & Industries

KREBSBIO · Pharma > Pharmaceuticals & Drugs · Chairman: R T Ravi · MD: Pabitrakumar Kalipada Bhattacharyya · Listing date: Aug. 23, 1995 · Employees: 390 · Hyderabad · http://krebsbiochem.com

Stock Price vs Company Growth

5.0%

18.9%

11.4%

12.7%

3.8%

14.0%

12.1%

all

4.1%

🤔 How to analyze this graph?

Last Traded Price

₹ 65.4 5.0%

38.5

65.7

Company Overview

Sales

23.7 Cr

Growth: -23.8%

Profit after Tax

-16.9 Cr

Growth: -25.9%

Micro Cap

141 Cr

P/S: 5.9x

Industry P/S: 2.5x

Fundamentals

Sales (Cr)	₹ 23.7
Growth	-23.8%
EBITDA	-23.0%
P/S	5.9x
Dividend	0.0%
P/E	-8.3x
Book Value	₹ -80.6
PEG Ratio	0.3x
ROE	10.0%
P/B	N/A

Shareholding Pattern

Institutions

Sun Pharmaceutical Industries Ltd

4.87 %

K Satish

2.05 %

Brescon Ventures Private Limited

1.97 %

Promoters

Ipca Laboratories Limited

49.65 %

Hemalatha Ravi

12.48 %

Avinash Ravi

9.93 %

Ajay Ravi

0.52 %

R T Ravi

0.11 %

Others

Increase Decrease No change

Company Profile Detailed

Krebs Biochemicals & Industries (KBIL) was established in the year 1991 as a Public Limited Company with the main objective of establishing commercially viable biotech processes with applications in Medicine, Agriculture Industry. The company has pioneered in the fermentation technology over the last decade. KBIL went into public in the year March 1994 to part finance its fermentation technology project.

Investors (43)

avinash....

hemalata...

shaaji.p...